Clik here to view.
Retracements and Moving Averages as Strategic Signals - Screen of the Week
Prior to last week's 3.6% bounce in the market (S&P 500), it had been down -8.9% from the highs on 9/14/12 to the lows on 11/16/12. The S&P, along with the other major indexes,
View ArticleClik here to view.
CR Bard Remains Neutral - Analyst Blog
We have reiterated our Neutral rating on CR Bard Inc. ( BCR ) following its third quarter results with a price target of $103. In the reported quarter, adjusted earnings of $1.64 per share
View ArticleClik here to view.
Teleflex Analyst Day Excerpts - Analyst Blog
Recently, Teleflex Incorporated ( TFX ) unveiled long-term growth plans during its annual investor and analyst day. The company also provided preliminary financial outlook for 2013.
View ArticleClik here to view.
COV Presents Positive Study Results - Analyst Blog
Covidien plc. ( COV ), a large-cap healthcare products company, has announced the five-year results of the ClosureFAST Long-Term European Multi-Center Study. The study revealed that the
View ArticleClik here to view.
Covidien to Acquire CV Ingenuity - Analyst Blog
Large-cap medical technologies company, Covidien plc. ( COV ) has entered into a definitive agreement to acquire Fremont, California-based medical device company, CV Ingenuity. Financial
View ArticleClik here to view.
Covidien Remains at Neutral - Analyst Blog
We have reiterated our Neutral recommendation on leading health care products maker, Covidien plc. ( COV ), with a target price of $60. The company's adjusted earnings per share (from
View ArticleClik here to view.
ANGO Beats on EPS, Tweaks View - Analyst Blog
AngioDynamics Inc. ( ANGO ) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ended November 30, 2012, beating the Zacks Consensus Estimate by a penny
View ArticleClik here to view.
Covidien Closes CV Ingenuity Buyout - Analyst Blog
Large-cap medical technologies company, Covidien plc. ( COV ) has successfully completed the acquisition of Fremont, California-based medical device company, CV Ingenuity. Both the parties
View ArticleClik here to view.
C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for January 17, 2013
C.R. Bard, Inc. ( BCR ) will begin trading ex-dividend on January 17, 2013. A cash dividend payment of $0.2 per share is scheduled to be paid on February 01, 2013. Shareholders who purchased
View ArticleClik here to view.
Covidien Begins SWIFT PRIME Study - Analyst Blog
International health care product major, Covidien plc. ( COV ), has initiated a new study, SWIFT PRIME. The main objective of this study is to find out the efficacy of the Solitaire FR
View ArticleClik here to view.
Covidien Wins FDA Approval - Analyst Blog
International health care product major, Covidien plc. ( COV ) recently revealed approval from the Food and Drug Administration ("FDA") for Gablofen (baclofen injection) in
View ArticleClik here to view.
Teleflex Wins GPO Agreement - Analyst Blog
Teleflex Incorporated ( TFX ), a global provider of medical devices used in critical care and surgery, recently won a new agreement with HealthTrust, a healthcare group purchasing
View ArticleClik here to view.
Earnings Preview: CR Bard Inc. - Analyst Blog
CR Bard Inc. ( BCR ) is set to report its fourth-quarter 2012 results after the market closes on Thursday, Jan 31. Let's see how things are shaping up prior to the announcement. In the
View ArticleClik here to view.
After-Hours Earnings Report for January 31, 2013 : CB, ED, WYNN, EMN, PFG,...
The following companies are expected to report earnings after hours on 01/31/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Chubb Corporation ( CB ) is
View ArticleClik here to view.
CR Bard Squarely Beats Estimates - Analyst Blog
CR Bard Inc. 's ( BCR ) fourth-quarter 2012 adjusted earnings of $1.70 per share beat the Zacks Consensus Estimate of $1.67 (flat year-over-year). Adjusted earnings exclude one-time items
View ArticleClik here to view.
CR Bard Reiterated at Neutral - Analyst Blog
On Mar 13, we retained Neutral recommendation on CR Bard Inc. ( BCR ) following its fourth-quarter results. Despite the upbeat results, the company's organic growth rate, especially in the
View ArticleClik here to view.
Yacktman Fund - Texas Billionaire Guru Adds and Sells First Quarter
Investor Guru and self-made billionaire Donald Yacktman once said, "Back in 1987, the day of the 500-point decline, I started buying like crazy ... I spent $40 million that day."
View ArticleClik here to view.
Will CR Bard Miss Earnings this Quarter? - Analyst Blog
CR Bard Inc. ( BCR ) is set to report first-quarter 2013 results after the market closes on Tuesday, Apr 23. Let's see how things are shaping up prior to the announcement. In the last
View ArticleClik here to view.
After-Hours Earnings Report for April 23, 2013 : AAPL, T, AMGN, NSC, BRCM,...
The following companies are expected to report earnings after hours on 04/23/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Apple Inc. ( AAPL ) is
View ArticleClik here to view.
C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for April 25, 2013
C.R. Bard, Inc. ( BCR ) will begin trading ex-dividend on April 25, 2013. A cash dividend payment of $0.2 per share is scheduled to be paid on May 10, 2013. Shareholders who purchased BCR stock
View Article
